Alnylam Pharmaceuticals | ALNY - 销售和管理费用

股票价格

321.18

每天变化

-6.07 -1.85%

每月一次

-0.37%

每年

41.94%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.47B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	销售和管理费用	更改		日
Acadia Pharmaceuticals	USD 146.73M		21.82M	2025-12
Agios Pharmaceuticals	USD 42.97M		1.7M	2025-12
Alnylam Pharmaceuticals	USD 285.06M		22.47M	2025-12
Amgen	USD 1.94B		237M	2025-12
Arrowhead Research	USD 46.02M		8.84M	2025-12
BioCryst Pharmaceuticals	USD 95.78M		12.77M	2025-12
BioMarin Pharmaceutical	USD 322.21M		98.79M	2025-12
Incyte	USD 390.41M		61.33M	2025-12
Ionis Pharmaceuticals	USD 130M		43.43M	2025-12
Moderna	USD 308M		40M	2025-12
Neurocrine Biosciences	USD 301.8M		10.2M	2025-12
Novartis	USD 3.44B		132M	2025-12
PTC Therapeutics	USD 87.2M		3.15M	2025-12
Regeneron Pharmaceuticals	USD 775M		117.2M	2025-12
Sangamo BioSciences	USD 9.64M		1.83M	2024-06
Sanofi	EUR 2.75B		455M	2025-12
Sarepta Therapeutics	USD 105.38M		28.27M	2025-12
Takeda	JPY 282.78B		29.23B	2025-12
Tectonic Therapeutic	USD 3.44M		1.52M	2025-12
Ultragenyx Pharmaceutical	USD 89M		2.38M	2025-12
Vertex Pharmaceuticals	USD 487M		41.9M	2025-12
Xencor	USD 17.04M		70.74M	2025-12